As U.S. manufacturers hit their stride, vaccine scarcity will soon turn to plenty as much of the world goes begging. And vaccine makers need answers now about what to do with the coming surplus.As U.S. manufacturers hit their stride, vaccine scarcity will soon turn to plenty as much of the world goes begging. And vaccine makers need answers now about what to do with the coming surplus.Vaccination and Immunization, United States Politics and Government, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Shortages, Biden, Joseph R Jr, AstraZeneca PLC, Moderna Inc, Pfizer IncRead More
